Check out our Image of the Day Archives for more awesome photos. Can't find the date you're looking for? It may have been a weekend or holiday, when we don't normally update our Image of the Day.
Eli Lilly and Company (NYSE: LLY) today announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial. Zepbound® (tirzepatide) provided a 47% greater relative weight ...
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs. The latest investment ...
Lilly now plans to file for approval to add the heart failure indication to the label for tirzepatide, which is already sold as Mounjaro for type 2 diabetes and Zepbound for obesity, later this year.
Dec 5 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant Prairie, Wisconsin earlier this year ...
LONDON — The U.K. will start offering Eli Lilly’s weight loss drug next year, but will restrict the medicine to people with the greatest need as the country tries to adapt to new ways of ...
Copyright 2024 The Associated Press. All Rights Reserved. David Ricks, chair and CEO of Eli Lilly, fields a question during an announcement of the company’s $3 ...
Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...
Dec 5 (Reuters) - President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (PFE.N), opens new tab and Eli Lilly (LLY.N), opens new tab as well as industry lobbying ...
Once fully operational, the company expects to add 750 highly skilled jobs to the more than 100 already at the site. KENOSHA, Wis. — Eli Lilly and Company announced Thursday a $3 billion ...